saxenda vs tirzepatide Mounjaro | Weight-loss injections GLP-1 medications are marketed to

The metabolic effects of these Liver-EVs on skeletal muscle cells were further elucidated using targeted metabolomics analysis

Patients with a history of acute or chronic pancreatitis, gallstone disease, triglyceride levels above 500 mg/dL, or alcohol use disorder face naturally higher baseline risk

[8] With that framing set, the sections below compare the two on structure, mechanism, regulatory status, human evidence, safety, and the single most important caveat of all: no published trial has ever compared them head-to-head

It's also worth noting that the GLP-1 bone story isn't uniformly negative in the research